Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lomustine in Older AML (LAM-SA 2007)
NCT00590837Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Feb 2008
- Primary completion
- Dec 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of lomustine in acute myeloid leukemia (AML), sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Feb 2008; status: completed.
02
Drugs
lomustine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00590837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00590837.